HomeCYCMF • OTCMKTS
add
Cyclopharm Limited
Market news
Financials
Income Statement
Revenue
Net income
| (AUD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 8.45M | 17.66% |
Operating expense | 9.70M | 13.06% |
Net income | -4.77M | -67.59% |
Net profit margin | -56.39 | -42.43% |
Earnings per share | — | — |
EBITDA | -4.46M | -27.57% |
Effective tax rate | 4.61% | — |
Balance Sheet
Total assets
Total liabilities
| (AUD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 6.63M | -67.78% |
Total assets | 46.10M | -25.80% |
Total liabilities | 18.99M | -2.10% |
Total equity | 27.11M | — |
Shares outstanding | 109.81M | — |
Price to book | — | — |
Return on assets | -26.59% | — |
Return on capital | -35.17% | — |
Cash Flow
Net change in cash
| (AUD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -4.77M | -67.59% |
Cash from operations | -4.91M | -58.35% |
Cash from investing | 1.64M | 707.52% |
Cash from financing | -289.53K | -35.24% |
Net change in cash | -2.89M | 17.31% |
Free cash flow | -3.71M | -78.89% |
About
Founded
1986
Employees
97
